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S24 Infections in People with HIV
Methods: Patients were children (<15 years old) presenting for
HIV care between February 2005, and March 2007 at five primary
healthcare clinics in South Western Cameroon. Participants who
met the national treatment criteria and gave their informed writ-
ten consent were randomly allocated to receive one of the three
drugs (ARTs) (zidovudine or stavudine plus lamivudine plus nevirap-
ine or efavirenz). The subjects were treated as recommended and
followed up by nurses and medical officers in the various health-
care clinics. During which time, the survival rate, weight gain, CD4
cell count, and haematologic responses were evaluated.
Results: Of 5043 children enrolled into HIV care, 3432 (68.1%)
started ART. Of those initiating ART, the median age was 80 months
(range: 36-125), 2073 (60.4%) were female, and 2542 (74.1%) with
WHO stage information at stage III or later. During analysis, 230
children (6.7%) had withdrawn from care and 421(12.3%) were at
least 30 days late for follow-up. Of the remaining 3432 children
receiving ART, 245 (7.1%) died over 3512 child-years of follow-up
(mortality rate, 7.8 deaths per 100 child-years; 95% confidence in-
terval [CI]: 6.3-8.4); of these deaths, 167 (68.2%) occurred within 3
months of therapy initiation (early mortality rate, 15.7/100 child-
years; post-90-day mortality rate, 3.6/100 child-years). Mortal-
ity was associated with CD4 cell depletion, lower weight-for-age,
younger age, and anemia in multivariate analysis. The mean CD4
cell percentage at ART initiation among the 1897 children who had
at least a repeat measurement was 14.2% (95% CI: 13.3%-15.7%)
and increased to 26.8% (95% CI: 26.0%-27.6%) at 6 months, 29.3%
(95% CI: 28.7%-30.4%) at 12 months, 30.1% (95% CI: 29.7%-30.8%) at
18 months, and 31.2% (95% CI: 30.2%-31.9%) at 24 months.
Conclusions: Care provided by caregivers may result in good clini-
cal and immunologic outcomes for HIV-infected children in primary
health care settings in resource poor settings. Mortality rate dur-
ing the first 3 months of therapy is high, highlighting the need for
earlier intervention in these patients age group.
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Background: In Nigeria, the HIV/AIDS epidemic has reached an
alarming level and more persons get infected on daily basis. One of
the major problems of this epidemic is the opportunistic infections
usually associated to it. With no cure in sight, it has been suggested
that the best practice is to limit the secondary infections as much
as possible. In several developing countries, not many studies have
been conducted to ascertain the level of involvement of some of
these opportunistic pathogens; and where substantial studies have
been carried out, there is need to monitor the trend considering
that in recent times, several new and relatively strange microor-
ganisms have been reportedly isolated from similar patients.
Objectives: To ascertain the prevalence of secondary fungal infec-
tions in HIV/AIDS patients in Nigeria at the moment and the suscep-
tibility of the isolates to some conventional and non-conventional
(ethanolic medicinal plant extracts) antifungal agents. These
medicinal plant extracts, though in use by some patients, have
not been tested against isolates obtained directly from HIV/AIDS
patients.
Methods: Oral and nasal swabs collected from different categories
of HIV/AIDS patients attending different hospitals and samples
were plated on general purpose medium for fungi. Relevant subcul-
tures were made and identified. MICs of the antimicrobial agents
were determined following the CLSI guidelines. Prior to this, some
of the medicinal plants collected from the patients were identified
and prepared using standard methods.
Results: Several fungal isolates viz: Candida albicans and Non-
albicans Candida species which showed similar prevalence, fol-
lowed by Aspergillus, Cryptococcus, Histoplasma and Scedospo-
rium species. Other rare fungal species not previously reported in
our patients had a total prevalence of 20%.They were mainly envi-
ronmental pathogens which may have evolved by ecological shift.
Compared to our previous data, resistance is still on the increase.
However, medicinal plant extracts showed promising activities on
some of the isolates which were hitherto resistant to some of the
conventional agents.
Conclusions: Some new organisms are increasingly getting involved
as secondary pathogens in HIV/AIDS patients in Nigeria. There is
need to continue to monitor and report the trend so as to assist
clinicians in handling these patients.
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Background: Nucleoside RT inhibitors (NRTIs) are among the most
potent anti-HIV agents. All approved NRTIs act as chain terminators
because they lack a 3' OH, and it has long been considered that the
absence of the 3' OH is essential for antiviral activity. However, this
feature can also impart detrimental properties to the inhibitor,
such as reduced affinity for RT compared to the analogous dNTP
substrate, as well as reduced intracellular conversion to the active
nucleoside triphosphate. In an effort to overcome this problem,
it was shown that certain nucleosides that retain the 3' OH group
and have substitutions at the 4' of the deoxyribose sugar and 2
position of the base have exceptional antiviral properties. One of
these compounds, 4' -ethynyl, 2-fluoro deoxy-adenosine (4' E-2FdA)
is the most potent NRTI inhibitor against wild-type and mutant re-
sistant HIV viruses described to date. We have recently reported
that 4' E-2FdA acts as a chain terminator despite the presence of
an accessible 3' OH.
Objectives: Our goal is to characterize inhibitors that have a 3'
OH group, but have a modification at their 4' position and identify
their mechanism of action.
Methods: The behaviour of RT in the presence of the 4' modi-
fied nucleotide analog was studied using enzymology assays such
as primer extension and gel mobility shift assays.
Results: We report here the molecular mechanism of action of
this unusual inhibitor. We show that after 4' E-2FdA-MP incorpo-
ration, RT is unable to bind the next incoming dNTP. We analyzed
the translocation status of RT on different sequences terminated
with 4' E-2FdA-MP, and found that even at sequences when RT is
naturally found post-translocated, the inhibitor prevents transloca-
tion. This decrease in translocation efficiency explains the reduced
binding of the next incoming dNTP and the termination of elon-
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gation. While the inhibitor stabilizes the 4' E-2FdA-MP-terminated
primer at the pre-translocation state, our preliminary experiments
show no significant increase in the pyrophosphate-dependent exci-
sion rate of 4' E-2FdA-MP as compared to ddAMP.
Conclusions: This highly potent chain termination activity arises
from difficulty of the primer 3' -terminus to translocate following
incorporation of the compound, and not from simple steric hin-
drance due to the 4' substitution. Therefore, we propose that 4' E-
2FdA is a Translocation-Deficient Reverse Transcriptase Inhibitor
(TDRTI) that acts by a novel mechanism.
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Background: A higher rates of HIV infections are transmitted
through homosexual contact. Most MSMs are youth and are an in-
credibly diverse group, in terms of both their economic circum-
stances and sexual attitudes and behavior.
Materials: Younger youth are more economically disadvantaged
than older youth. Young students are often more subject to peer.
Due to many reasons, MSMs are seduced by male sex workers
(MSWs). Most of them are either married or will become married,
thus having an impact upon women' s reproductive health.
Methods: On the one hand, Government' s different strategies for
national health program in terms of sexual health and HIV/AIDS
has shaded a negative impact among such vulnerable population,
on the other hand, due to a socio-cultural-religious reasons, those
behaviors are to a large extent invisible, often difficult to access
in terms of standard sexual health promotion framework of the
nation.
Result: The result is that those most needing information, educa-
tion and counseling are driven underground. Men and women are
not only at greater risk of being infected, but also HIV/AIDS affects
women also as caregivers in the family.
Conclusion: A urgent need to promote behaviors, which enable
to adopt a lifestyle without risk of HIV and to provide counseling
services is essential. When youth belong to an organization that
helps them and provides opportunities, they better avoid risky be-
haviors, including those that might lead to HIV/AIDS. Every social
sector should not discriminate/stigmatize them so that they can
create an environment to change their behavior. Regardless, there
should be ensured legal framework protections of human rights of
those sexual minorities.
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Background: In spite of the importance of the infections by in-
testinal coccidian in patients infected with the Human Immunode-
ficiency Virus (HIV) or with Acquired Immunodeficiency Syndrome
(AIDS), in Bolivar state still many clinical and epidemiologic aspects
of these infections in that group of patients are not known.
Objective: To determine the prevalence of intestinal coccidian
protozoa in adult patients with HIV/AIDS.
Methods: A study was made of type case/control with 39 stool sam-
ples of equal number of positive patients HIV or with AIDS (Group
of Cases) and 39 stool samples of equal number of patients hos-
pitalized by other causes or that went to a specialized consulta-
tion in the University Hospital Ruiz and Páez (Group Control), from
January-2004 to December-2005. The feces were put under direct
examination, concentration methods of Kato and Formol-ether and
Kinyoun staining.
Results: The prevalence of intestinal parasitism, in the 39 HIV/AIDS
patients, was of 79.49%; whereas in the control group was of
48.72% (n), the difference was statistically significant (p<0.05).
In both groups, 5 species of parasites or intestinal commensals
were diagnosed, emphasizing Blastocystis hominis with 58.97% in
patients HIV/AIDS and 28.21% in the control group. The global
prevalence of coccidian was of 23.08% (9/39) in HIV/AIDS pa-
tients, and 25.64%, in the control group (p>0.05). In HIV/AIDS pa-
tients, Isospora belli was the coccidian more frequently observed
(20.51%), whereas in the control group it was Cyclospora cayeta-
nensis (20.51%). There were not differences as far as sex (p> 0.05)
or the age of the patients infected with coccidian. The reason
for consultation more frequently referred by HIV/AIDS patients
was chronic diarrhea. In addition this group of cases consulted
10 times more frequently with chronic diarrhea than the control
group (OR: 9.81; p<0.05). In the group of cases, abdominal pain
(76.92%) and the diarrhea (71.79%) were the symptoms more com-
monly observed. HIV/AIDS patients parasited by coccidian showed
a count and lymphocyte relation of type CD4/CD8, below the nor-
mal values, mainly in the affected ones by I. belli and C. cayeta-
nensis.
Conclusions: A high prevalence of intestinal coccidian protozoa
in evaluated HIV/AIDS was determined, although there were no
demonstrated differences with the control group.
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Background: Infection is the leading cause of death in patients
with hematological malignancy and clinical presentations for viral
respiratory tract infection are in these patients often non-specific.
Therefore rapid and throughput laboratory technique that can de-
tect a panel of common viral infections is desirable. PCR detection
in clinical specimens with limited amount of RNA (e.g. nasopha-
ryngeal swabs) should include the internal control to ensure the
integrity of the assay. The aim of present study was to optimize
reverse transcription - polymerase chain reaction (RT-PCR) with in-
ternal control for routine detection of 13 most common respiratory
viruses in nasopharyngeal swabs (NS) and bronchoalveolar lavage
fluids (BALF).
Materials and Methods: 400 microlitres of NS or BALF were used
for RNA isolation. Nonhuman and nonviral (plant) control RNA ob-
tained by in vitro transcription was added to all samples before
further processing. Then RNA was isolated using QIAamp Viral RNA
Mini Kit (Qiagen). Viral RNA of respiratory syncytial virus (RSV),
parainfluenza virus subtypes 1, 2, 3 (PIV 1, 2, 3), adenoviruses
